Search Results 881-890 of 17238 for monoclonal antibody

1. Multiple sclerosis - Symptoms and causes - Mayo Clinic

   Clinical use of monoclonal antibody disease-modifying therapies for multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 19, 2024 ...

2. Study to Assess the Safety and Effectiveness of Shingrix Vaccine in Patients with Hematologic Malignancies - Mayo Clinic

   Patients receiving any other concomitant CLL directed therapy such as anti-CD20 monoclonal antibody (such as rituximab, ofatumumab or obinutuzumab).

3. Ph 3 Trial of Blinatumomab vs Investigator's Choice of Chemotherapy in Patients with Relapsed or Refractory ALL - Mayo Clinic

   Blinatumomab, a bispecific monoclonal antibody construct that enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic ...

4. Immune globulin-stwk (intravenous route) - Side effects & uses - Mayo Clinic

   Description. Immune globulin-stwk injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

5. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

   Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients ... A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to ...

6. Cyclophosphamide and Vaccine Therapy in Treating Patients with Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   ... monoclonal antibodies, small molecule inhibitors) for this cancer; Known history of autoimmune disease; Any contraindication to receiving sargramostim (GM-CSF) ...

7. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   Part 2 (Cohort Expansion): Subjects must have received adequate prior therapy including at a minimum including at a minimum anti-CD20 monoclonal antibody ...

8. Publications - Madiha Fida, M.B.B.S. - Mayo Clinic

   ... monoclonal antibody escape mutation in a persistently infected, immunocompromised individual. Virus Evol. 2023; 9 (2):veac104 Epub 2022 Nov 05. View PubMed ...

9. A Study of Pembrolizumab Alone as Therapy for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   Prior anti-cancer monoclonal antibody (mAb) therapy for direct anti-neoplastic treatment within 4 weeks prior to study Day 1; Prior chemotherapy, targeted ...

10. A Study to Assess the Effectiveness, Safety and Tolerability of Lu AF82422 in Patients with Multiple System Atrophy - Mayo Clinic

    - The participant has been treated with an anti-?-synuclein monoclonal antibody, mesenchymal stem cells or an inhibitor of ?-synuclein aggregation within ...